Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Hereditary Angio Edema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00168103
What this trial is testing

Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
CSL Behring 126
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Not applicableStudy completedNCT01108848
What this trial is testing

Patient Registry Study of Berinert® in Normal Clinical Practice

Who this might be right for
Includes: Hereditary Angioedema
CSL Behring 318
Large-scale testing (Phase 3)Study completedNCT00912093
What this trial is testing

Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Who this might be right for
Hereditary Angioedema
Shire 98
Large-scale testing (Phase 3)Study completedNCT00225147
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaAngioneurotic Edema
Pharming Technologies B.V. 77
Large-scale testing (Phase 3)Study completedNCT00262288
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Genetic Disorders
Pharming Technologies B.V. 14
Post-approval studies (Phase 4)Study completedNCT01457430
What this trial is testing

Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE

Who this might be right for
Hereditary Angioedema
Massachusetts General Hospital 19
Large-scale testing (Phase 3)Study completedNCT00289211
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 83
Large-scale testing (Phase 3)WithdrawnNCT04898309
What this trial is testing

Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
AO GENERIUM
Not applicableNo Longer AvailableNCT04583007
What this trial is testing

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

Who this might be right for
Hereditary Angioedema (HAE)Angioedema
Shire
Testing effectiveness (Phase 2)Study completedNCT01359969
What this trial is testing

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 57
Large-scale testing (Phase 3)Enrolling By InvitationNCT05396105
What this trial is testing

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+14 more
Pharvaris Netherlands B.V. 150
Large-scale testing (Phase 3)Study completedNCT02586805
What this trial is testing

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 125
Large-scale testing (Phase 3)Study completedNCT00097695
What this trial is testing

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Who this might be right for
Angioedema
Shire 84
Large-scale testing (Phase 3)Study completedNCT00438815
What this trial is testing

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 113
Large-scale testing (Phase 3)Study completedNCT04070326
What this trial is testing

Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children

Who this might be right for
Hereditary Angioedema
Shire 21
Large-scale testing (Phase 3)Study completedNCT01188564
What this trial is testing

Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 75
Testing effectiveness (Phase 2)Study completedNCT03240133
What this trial is testing

Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
BioCryst Pharmaceuticals 58
Large-scale testing (Phase 3)Study completedNCT01005888
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 26
Large-scale testing (Phase 3)Study completedNCT00262080
What this trial is testing

Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 91
Next Page